About Gobia Enterprises

Gobia Enterprises is a family-owned group of companies and investment firm. Driven by a passion for business development and the commercialisation of innovations, we strive to create value and foster growth in every company we support.

Focus on Long-Term Active Ownership

Gobia is more than a traditional investment firm – we are an engaged partner, combining deep expertise with a forward-looking perspective. Through long-term active ownership, we aim to foster stability and continuity for the companies we invest in, while driving innovation and sustainability across all aspects of their operations.

A Wide Network

Our extensive network in industry and business provides us with a unique ability to identify and capitalise on opportunities. International expansion is one of our key strengths, and we are dedicated to supporting our companies in their growth on global markets.

Our history

1989

Jan G Smith founded together with his brother Leif Smith ABIGO Medical

1997

ABIGO Medical acquires the advanced wound care product Sorbact

2020

ABIGO Medical is sold to Essity

2020

First investment in Profundus

2020

First investment in Gasporox (Publ)

2021

The new company Circius Pharma is formed

2021

First investment in Beamonics

2022

First investment in Kromnigon

2023

Acquisition of the Swedish Herbal Medicine Institute

2024

Acquisition of Roux Healthcare, a company with a strong position in the service of medical equipment

Want to get in touch with us?

We invest in companies and ideas with clear potential for development and growth. Our primary focus is on companies where our experience can have significant impact, innovations with international potential. However, we remain open to opportunities with more established companies when the right conditions align.

Contact us

We invest in companies and ideas with clear potential for development and growth. Our primary focus is on companies where our experience can have significant impact, innovations with international potential. However, we remain open to opportunities with more established companies when the right conditions align.